Stock 460 SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sihuan Pharmaceutical Holdings Group Ltd.

Equities

460

BMG8162K1137

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
0.56 HKD +3.70% Intraday chart for Sihuan Pharmaceutical Holdings Group Ltd. +9.80% -13.85%
Apr. 25 Sihuan Pharma Unit Wins Bid to Supply Insulin Products to Chinese Government MT
Mar. 29 Sihuan Pharmaceutical Narrows 2023 Loss on Absence of Asset, Investment Impairments MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 11,393 7,867 6,533 11,251 7,828 4,811 4,811 -
Enterprise Value (EV) 1 8,079 7,867 6,533 11,251 7,828 5,512 4,811 4,811
P/E ratio 7.03 x -2.86 x 13 x 27.5 x -4.09 x -114 x 51.8 x 13 x
Yield 1.41% 2.05% 2.03% 1.08% - 7.72% 9.65% 9.65%
Capitalization / Revenue 3.91 x 2.73 x 2.65 x 3.42 x - 2.96 x 1.76 x 1.51 x
EV / Revenue 3.91 x 2.73 x 2.65 x 3.42 x - 2.96 x 1.76 x 1.51 x
EV / EBITDA 5.14 x - 6.34 x 10.6 x - -35.8 x -45 x 36.4 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 0.91 x 0.82 x 0.71 x 1.35 x - 0.94 x 1 x 1.02 x
Nbr of stocks (in thousands) 9,471,082 9,465,682 9,465,682 9,329,999 9,329,999 9,281,566 9,281,566 -
Reference price 2 1.203 0.8311 0.6902 1.206 0.8390 0.5184 0.5184 0.5184
Announcement Date 3/18/19 3/24/20 3/23/21 3/29/22 3/24/23 3/28/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 2,917 2,887 2,464 3,291 - 1,861 2,733 3,186
EBITDA 1 2,217 - 1,031 1,065 - -153.9 -107 132
EBIT 1 2,026 1,517 787.1 763.9 - -193.2 -305 -74
Operating Margin 69.44% 52.53% 31.94% 23.21% - -10.39% -11.16% -2.32%
Earnings before Tax (EBT) 1 2,012 -2,467 765.8 486 - -161.3 -589 -385
Net income 1 1,620 -2,753 473.4 416.5 -1,915 -54.02 107 337
Net margin 55.53% -95.37% 19.21% 12.65% - -2.9% 3.92% 10.58%
EPS 2 0.1710 -0.2910 0.0530 0.0439 -0.2052 -0.005200 0.0100 0.0400
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 0.0170 0.0170 0.0140 0.0130 - 0.0400 0.0500 0.0500
Announcement Date 3/18/19 3/24/20 3/23/21 3/29/22 3/24/23 3/28/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - - -
Net Cash position 3,315 - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 13.7% -24.9% 5.04% 4.77% - -2.8% 2.3% 6.7%
ROA (Net income/ Total Assets) 11.2% -19.7% 3.7% 3.03% - -1.1% 0.9% 2.7%
Assets 1 14,518 14,007 12,808 13,769 - 11,727 11,889 12,481
Book Value Per Share 2 1.320 1.010 0.9700 0.8900 - 0.5500 0.5200 0.5100
Cash Flow per Share 2 0.1900 0.1500 - 0.0700 - 0.0100 0.0400 0.0700
Capex 1 389 590 581 767 - 350 350 350
Capex / Sales 13.35% 20.43% 23.56% 23.32% - 14.89% 12.81% 10.99%
Announcement Date 3/18/19 3/24/20 3/23/21 3/29/22 3/24/23 3/28/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.56
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. Stock Sihuan Pharmaceutical Holdings Group Ltd.
-13.85% 664M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 460 Stock
  4. Financials Sihuan Pharmaceutical Holdings Group Ltd.